These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21569507)

  • 1. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
    Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
    Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.
    Régent A; Dib H; Ly KH; Agard C; Tamby MC; Tamas N; Weksler B; Federici C; Broussard C; Guillevin L; Mouthon L
    Arthritis Res Ther; 2011 Jun; 13(3):R107. PubMed ID: 21711540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional electrophoresis and mass spectrometry identification of proteins bound by a murine monoclonal anti-cardiolipin antibody: a powerful technique to characterize the cross-reactivity of a single autoantibody.
    Thebault S; Gilbert D; Machour N; Marvin L; Lange C; Tron F; Charlionet R
    Electrophoresis; 2000 Jul; 21(12):2531-9. PubMed ID: 10939468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrosome proteins: a major class of autoantigens in scleroderma.
    Gavanescu I; Vazquez-Abad D; McCauley J; Senecal JL; Doxsey S
    J Clin Immunol; 1999 May; 19(3):166-71. PubMed ID: 10404401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome.
    Matsuda KM; Kotani H; Yamaguchi K; Ono C; Okumura T; Ogawa K; Miya A; Sato A; Uchino R; Yumi M; Matsunaka H; Kono M; Norimatsu Y; Hisamoto T; Kawanabe R; Kuzumi A; Fukasawa T; Yoshizaki-Ogawa A; Okamura T; Shoda H; Fujio K; Matsushita T; Goshima N; Sato S; Yoshizaki A
    Rheumatology (Oxford); 2024 Oct; 63(10):2865-2873. PubMed ID: 38290780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
    Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Broussard C; Bussone G; Yaïci A; Hotellier F; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Am J Respir Crit Care Med; 2008 May; 177(10):1128-34. PubMed ID: 18276943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics characterization of CENP-B epitope in Moroccan scleroderma patients with anti-centromere autoantibodies.
    Zian Z; Bennani Mechita M; Hamdouch K; Maamar M; Barakat A; Ghailani Nourouti N; El Aouad R; Valdivia MM; Arji N
    Immunol Lett; 2020 May; 221():1-5. PubMed ID: 32057908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
    Montecucco C; Caporali R; Cobianchi F; Biamonti G
    Arthritis Rheum; 1996 Oct; 39(10):1669-76. PubMed ID: 8843857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
    Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
    Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
    Dib H; Tamby MC; Bussone G; Regent A; Berezné A; Lafine C; Broussard C; Simonneau G; Guillevin L; Witko-Sarsat V; Humbert M; Mouthon L
    Eur Respir J; 2012 Jun; 39(6):1405-14. PubMed ID: 22005913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibody in systemic sclerosis (scleroderma).
    Okano Y
    Rheum Dis Clin North Am; 1996 Nov; 22(4):709-35. PubMed ID: 8923592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
    Vulsteke JB; Smith V; Bonroy C; Derua R; Blockmans D; De Haes P; Vanderschueren S; Lenaerts JL; Claeys KG; Wuyts WA; Verschueren P; Vanhandsaeme G; Piette Y; De Langhe E; Bossuyt X
    J Autoimmun; 2023 Feb; 135():102988. PubMed ID: 36634459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
    Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
    Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
    Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis.
    Bost C; Fortenfant F; Blancher A; Pugnet G; Renaudineau Y
    Clin Immunol; 2021 Aug; 229():108774. PubMed ID: 34111525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.